{
    "nctId": "NCT06433804",
    "briefTitle": "Clinicopathological Parameters of HER2 Low Breast Cancers",
    "officialTitle": "Exploring the Clinicopathological Parameters of HER2 Low Breast Cancers",
    "overallStatus": "COMPLETED",
    "conditions": "HER2 Low Breast Cancers",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 70,
    "primaryOutcomeMeasure": "Age (in years)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* All histologically proven cases of breast cancer in the 2 years from January 2022- December 2023\n\nExclusion Criteria:\n\n* Benign breast tumors",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}